BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leung DT, Lim PL, Cheung TH, Wong RR, Yim SF, Ng MH, Tam FC, Chung TK, Wong YF. Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients. PLoS One 2016;11:e0160412. [PMID: 27494141 DOI: 10.1371/journal.pone.0160412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Qin S, Yi L, Liang Y, Chen Y, Wang W, Liao Y, Zhang C, Huang H, Huang J, Yao S. Biological and Clinicopathological Characteristics of OPN in Cervical Cancers. Front Genet 2022;13:836509. [DOI: 10.3389/fgene.2022.836509] [Reference Citation Analysis]
2 Cappellano G, Vecchio D, Magistrelli L, Clemente N, Raineri D, Barbero Mazzucca C, Virgilio E, Dianzani U, Chiocchetti A, Comi C. The Yin-Yang of osteopontin in nervous system diseases: damage versus repair. Neural Regen Res 2021;16:1131-7. [PMID: 33269761 DOI: 10.4103/1673-5374.300328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sharifi L, Nowroozi MR, Amini E, Arami MK, Ayati M, Mohsenzadegan M. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting. Int Immunopharmacol 2019;76:105880. [PMID: 31522016 DOI: 10.1016/j.intimp.2019.105880] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
4 Xu X, Jiang X, Chen L, Zhao Y, Huang Z, Zhou H, Shi M. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells. Cancer Biother Radiopharm 2019;34:559-65. [PMID: 31436472 DOI: 10.1089/cbr.2019.2858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
5 Łaniewski P, Cui H, Roe DJ, Barnes D, Goulder A, Monk BJ, Greenspan DL, Chase DM, Herbst-Kralovetz MM. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci Rep 2019;9:7333. [PMID: 31089160 DOI: 10.1038/s41598-019-43849-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
6 Han X, Wang W, He J, Jiang L, Li X. Osteopontin as a biomarker for osteosarcoma therapy and prognosis. Oncol Lett 2019;17:2592-8. [PMID: 30854034 DOI: 10.3892/ol.2019.9905] [Cited by in Crossref: 13] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
7 Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE, Voiculescu V, Mamoulakis C, Tzanakakis G, Spandidos DA, Drakoulis N, Tsatsakis AM. Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int J Oncol 2018;52:637-55. [PMID: 29393378 DOI: 10.3892/ijo.2018.4256] [Cited by in Crossref: 32] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]